Paper39772007
Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions.
Hsiung KC and 3 others. Vaccines (Basel), 2024. Cited by 13 papers, by iCite.
Cite this record
ConductScience Library. Vaccine Strategies Against RNA Viruses: Current Advances and Future Directions. Papers, record 39772007. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39772007
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| CORPD1J0061-63 | Chang Gung Memorial Hospital | PubMed |
Source PubMed
References252
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20610717 | T cell responses are required for protection from clinical disease and for virus clearance in severe acute respiratory syndrome coronavirus-infected mice. | J Virol | 2010 | https://conductscience.org/library/papers/20610717 | PubMed |
| 2 | 31067370 | Transmission of Nipah Virus - 14 Years of Investigations in Bangladesh. | N Engl J Med | 2019 | https://conductscience.org/library/papers/31067370 | PubMed |
| 3 | 3166919 | Pulmonary epithelial permeability in bronchiectasis. | Br J Dis Chest | 1988 | https://conductscience.org/library/papers/3166919 | PubMed |
| 4 | 34276608 | Altering Compositional Properties of Viral Genomes to Design Live-Attenuated Vaccines. | Front Microbiol | 2021 | https://conductscience.org/library/papers/34276608 | PubMed |
| 5 | 32075877 | Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. | Science | 2020 | https://conductscience.org/library/papers/32075877 | PubMed |
| 6 | 26752261 | PLGA particulate delivery systems for subunit vaccines: Linking particle properties to immunogenicity. | Hum Vaccin Immunother | 2016 | https://conductscience.org/library/papers/26752261 | PubMed |
| 7 | 16111635 | Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA. | Immunity | 2005 | https://conductscience.org/library/papers/16111635 | PubMed |
| 8 | 9655482 | Virus-specific CD8+ T cells in primary and secondary influenza pneumonia. | Immunity | 1998 | https://conductscience.org/library/papers/9655482 | PubMed |
| 9 | 36560560 | mRNA-Based Vaccines and Therapeutics for COVID-19 and Future Pandemics. | Vaccines (Basel) | 2022 | https://conductscience.org/library/papers/36560560 | PubMed |
| 10 | 35343760 | Molecular Virology of SARS-CoV-2 and Related Coronaviruses. | Microbiol Mol Biol Rev | 2022 | https://conductscience.org/library/papers/35343760 | PubMed |
| 11 | 36106872 | Respiratory Vaccination with Hemagglutinin Nanoliposomes Protects Mice from Homologous and Heterologous Strains of Influenza Virus. | J Virol | 2022 | https://conductscience.org/library/papers/36106872 | PubMed |
| 12 | 11337471 | The complete genome sequence of the lactic acid bacterium Lactococcus lactis ssp. lactis IL1403. | Genome Res | 2001 | https://conductscience.org/library/papers/11337471 | PubMed |
| 13 | 32456079 | N-Terminal Fatty Acids of NEFMUT Are Required for the CD8+ T-Cell Immunogenicity of In Vivo Engineered Extracellular Vesicles. | Vaccines (Basel) | 2020 | https://conductscience.org/library/papers/32456079 | PubMed |
| 14 | 33824489 | Emerging concepts in the science of vaccine adjuvants. | Nat Rev Drug Discov | 2021 | https://conductscience.org/library/papers/33824489 | PubMed |
| 15 | 21576510 | Lack of peripheral memory B cell responses in recovered patients with severe acute respiratory syndrome: a six-year follow-up study. | J Immunol | 2011 | https://conductscience.org/library/papers/21576510 | PubMed |
| 16 | 18797453 | Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. | Mol Ther | 2008 | https://conductscience.org/library/papers/18797453 | PubMed |
| 17 | 36118203 | Viral vector and nucleic acid vaccines against COVID-19: A narrative review. | Front Microbiol | 2022 | https://conductscience.org/library/papers/36118203 | PubMed |
| 18 | 23806514 | Protective and dysregulated T cell immunity in RSV infection. | Curr Opin Virol | 2013 | https://conductscience.org/library/papers/23806514 | PubMed |
| 19 | 18288193 | Global trends in emerging infectious diseases. | Nature | 2008 | https://conductscience.org/library/papers/18288193 | PubMed |
| 20 | 33321075 | Predicted Cellular Immunity Population Coverage Gaps for SARS-CoV-2 Subunit Vaccines and Their Augmentation by Compact Peptide Sets. | Cell Syst | 2021 | https://conductscience.org/library/papers/33321075 | PubMed |
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 13 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42797601 | Research Progress, Application, and Industrialization Prospects of Circular RNA Vaccines in Viral Diseases. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/42797601 | PubMed |
| 42781491 | Chimeric SARS-CoV-2 vaccine vectors stably incorporating the functional glycoprotein of VSV. | iScience | 2026 | https://conductscience.org/library/papers/42781491 | PubMed |
| 41999993 | From legacy to innovation: A comprehensive review of vaccine platforms against viral infections. | Virus Res | 2026 | https://conductscience.org/library/papers/41999993 | PubMed |
| 41600980 | Broadening SARS-CoV-2 Immunity by Combining ORFV and Protein-Based Vaccines. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41600980 | PubMed |
| 41425583 | Next-generation vaccines against bacterial pathogens: mRNA and beyond. | Front Immunol | 2025 | https://conductscience.org/library/papers/41425583 | PubMed |
| 41341596 | Heterologous ORFV-Ad26 vaccination broadens antibody breadth and amplifies cellular immunity against SARS-CoV-2 spike. | Front Immunol | 2025 | https://conductscience.org/library/papers/41341596 | PubMed |
| 41025086 | Recent advances in avian influenza virus: Molecular pathogenesis, emerging strains, and next-generation therapeutics. | World J Virol | 2025 | https://conductscience.org/library/papers/41025086 | PubMed |
| 40872886 | Humoral and Memory B Cell Responses Following SARS-CoV-2 Infection and mRNA Vaccination. | Vaccines (Basel) | 2025 | https://conductscience.org/library/papers/40872886 | PubMed |
| 40144393 | mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy. | Front Bioeng Biotechnol | 2025 | https://conductscience.org/library/papers/40144393 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39772007
GET https://conductscience.org/api/papers/v1/39772007/references?page=2